Home/Filings/4/0001209191-21-058175
4//SEC Filing

Rawat Mohit 4

Accession 0001209191-21-058175

CIK 0001805890other

Filed

Sep 29, 8:00 PM ET

Accepted

Sep 30, 4:06 PM ET

Size

5.5 KB

Accession

0001209191-21-058175

Insider Transaction Report

Form 4
Period: 2021-09-27
Rawat Mohit
President and CBO
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-09-27+257,000257,000 total
    Exercise: $8.26Exp: 2031-09-27Common Stock (257,000 underlying)
Footnotes (1)
  • [F1]Twenty-five percent (25%) of the shares subject to this option shall vest and become exercisable on the first anniversary of the grant date and the remainder shall vest and become exercisable in 36 substantially equal monthly installments thereafter.

Issuer

Fusion Pharmaceuticals Inc.

CIK 0001805890

Entity typeother

Related Parties

1
  • filerCIK 0001885800

Filing Metadata

Form type
4
Filed
Sep 29, 8:00 PM ET
Accepted
Sep 30, 4:06 PM ET
Size
5.5 KB